Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
The primary purpose of this study is to see if Sym024 is safe and tolerable as monotherapy and in combination with Sym021 in patients with solid tumor malignancies.
创建时间：
2020-11-15
